Teva’s latest quarter was even worse than already-low expectations By: MarketWatch November 02, 2017 at 09:56 AM EDT Shares plummeted nearly 20% on Thursday, extending a more than 40% loss since the company’s last earnings. Read More >> Related Stocks: Mylan Teva Pharmaceutical Industries ADR